Why it was recalled
Failed Dissolution Specifications
Product description
Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-6734-61
Lot numbers, UPCs & expiration codes
Lot # N02425, Exp Date: 05/31/2027.
Where it was sold
US Nationwide.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0485-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Mar 24, 2026
- FDA report date
- Apr 22, 2026
- Quantity
- N/A
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- The Harvard Drug Group LLC
Original FDA data
Every field from FDA enforcement report D-0485-2026, exactly as published.
Show all FDA fields
- City
- Dublin
- State
- OH
- Status
- Ongoing
- Country
- United States
- Event ID
- 98672
- Address
- 7000 Cardinal Pl
- Code information
- Lot # N02425, Exp Date: 05/31/2027.
- Postal code
- 43017-1091
- Report date
- Apr 22, 2026
- Product type
- Drugs
- Recall number
- D-0485-2026
- Classification
- Class II
- Recalling firm
- The Harvard Drug Group LLC
- Reason for recall
- Failed Dissolution Specifications
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-6734-61
- Distribution pattern
- US Nationwide.
- Recall initiation date
- Mar 24, 2026
- Initial firm notification
- Letter
- Center classification date
- Apr 17, 2026